Latest Trials
| EudraCT Number: 2006-003087-59 | Sponsor Protocol Number: EFC6193 | Start Date: 2006-11-29 | |||||||||||
| Sponsor Name: sanofi aventis recherche et developpement | |||||||||||||
| Full Title: A Randomized, Open Label Multi-Center Study of XRP6258 At 25 mg/m2 in Combination With Prednisone Every 3 Weeks Compared To Mitoxantrone in Combination With Prednisone For The Treatment of Hormone ... | |||||||||||||
| Medical condition: Hormone Refractory Metastatic Prostate Cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: CZ (Completed) DE (Completed) HU (Completed) BE (Completed) NL (Completed) SK (Completed) DK (Completed) SE (Completed) FI (Completed) IT (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||